Fuente: WIPO "tomato" The disclosure relates to products and methods for treatment of autosomal dominant genetic diseases involving diversified disease-causing mutations. The products and methods use Type I CRISPR in a mutation-independent way to treat autosomal dominant genetic diseases such as autosomal dominant retinitis pigmentosa.